The National Institutes of Health (NIH) is inviting applications for the Rare Diseases Clinical Research Consortia (RDCRC) as part of the Rare Diseases Clinical Research Network (RDCRN), with a focus on advancing the diagnosis, management, and treatment of rare diseases affecting fewer than 200,000 individuals in the U.S. This funding opportunity, structured as a Cooperative Agreement, encourages both new and renewal applications that emphasize collaborative, patient-centered research and the importance of early diagnosis and clinical trial readiness. The RDCRCs will engage with patient advocacy groups and utilize innovative methodologies to enhance therapeutic development, with an award ceiling of $1 million available for successful applicants. Interested parties should submit their applications by August 19, 2024, and can direct inquiries to grantsinfo@nih.gov for further information.